Telix Pharmaceuticals Ltd. has agreed to acquire ITM Isotope Technologies Munich SE for up to $2.35 billion, seeking greater control of isotope supply and manufacturing...
Researchers at the National Institutes of Health (NIH) have shown that the host-targeted immunosuppressive drug mycophenolic acid (MPA) is a contributor to drug resistance...
Even as the treatment potential for GLP-1 drugs continues to expand beyond metabolic indications, recognition grows for the scientific breakthroughs that led to the...
Telix Pharmaceuticals Ltd. has agreed to acquire ITM Isotope Technologies Munich SE for up to $2.35 billion, seeking greater control of isotope supply and manufacturing...
